TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T92072	Adenosine A1 receptor	D0XE1C	Regadenoson	Approved	219024	C15H18N8O5	390.35	CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N	Ki > 16460000 nM	Non binder
T92072	Adenosine A1 receptor	D0J2UW	CGS 21680	Terminated	3086599	C23H29N7O6	499.5	CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=C(N=C32)NCCC4=CC=C(C=C4)CCC(=O)O)N)O)O	EC50 = 630957.34 nM	Non binder
T92072	Adenosine A1 receptor	B79RCB	11-Methyl-4-(4-nitrophenyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-amine	Investigative	46205484	C13H10N8O2	310.27	CN1C=C2C(=N1)N=C(N3C2=NC(=N3)C4=CC=C(C=C4)[N+](=O)[O-])N	Ki > 300000 nM	Non binder
T92072	Adenosine A1 receptor	B8J7OZ	(2S,3S,4R,5R)-5-[2-[2-[4-[(3,5-Ditert-butyl-4-hydroxybenzoyl)amino]phenyl]ethylamino]-6-(2,2-diphenylethylamino)purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide	Investigative	57387822	C48H56N8O6	841	CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C(=O)NC2=CC=C(C=C2)CCNC3=NC(=C4C(=N3)N(C=N4)[C@H]5[C@@H]([C@@H]([C@H](O5)C(=O)NC)O)O)NCC(C6=CC=CC=C6)C7=CC=CC=C7	IC50 = 413267 nM	Non binder
T92072	Adenosine A1 receptor	BGM83D	6,7-Dimethoxy-4H-indeno[1,2-d][1,3]thiazol-2-amine;hydroiodide	Investigative	10292899	C12H13IN2O2S	376.22	COC1=C(C=C2C(=C1)CC3=C2N=C(S3)N)OC.I	EC50 = 63095734.45 nM	Non binder
T92072	Adenosine A1 receptor	BOZB05	(2-Amino-4H-indeno[1,2-d][1,3]thiazol-5-yl) acetate;hydroiodide	Investigative	9976651	C12H11IN2O2S	374.2	CC(=O)OC1=CC=CC2=C1CC3=C2N=C(S3)N.I	EC50 = 501187233.6 nM	Non binder